公司概覽
業務類別 Drug Manufacturers - Specialty & Generic
業務概覽 Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world byimproving access to treatments for various diseases.
公司地址 9, rue de Bitbourg, Luxembourg, LUX, L-1273
電話號碼 +352 4224500
傳真號碼 --
公司網頁 https://www.alvotech.com
員工數量 1068
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Faysal Kalmoua Director and Chief Operating Officer -- 27/03/2025
Mr. Joseph E. McClellan Chief Scientific Officer -- 27/03/2025
Mr. Joel Morales Chief Financial Officer -- 27/03/2025
Mr. Robert Wessman Chairman of the Board and Chief Executive Officer -- 27/03/2025
Ms. Tanya Zharov General Counsel -- 27/03/2025
 
董事會成員
董事會 職務 更新日期
Ms. Lisa Graver Independent Director 27/03/2025
Mr. Faysal Kalmoua Director and Chief Operating Officer 27/03/2025
Ms. Ann Merchant Independent Director 27/03/2025
Mr. Arni Hardarson Independent Director 27/03/2025
Mr. Robert Wessman Chairman of the Board and Chief Executive Officer 27/03/2025
Mr. Richard Davies Deputy Chairman of the Board 27/03/2025
Ms. Linda McGoldrick Independent Director 27/03/2025
Mr. Hjorleifur Palsson Independent Director 27/03/2025
Mr. Tomas Ekman Director 27/03/2025
 
所屬ETF (更新日期: 07/03/2026 04:26)
代號 名稱 佔比% 持有日期
IBBiShares Biotechnology ETF0.26%28/02/2026
VEUVanguard FTSE All-Wld ex-US ETF0.08%31/01/2026
SCHESchwab Emerging Markets Equity ETF™0.04%28/02/2026
ONEQFidelity Nasdaq Composite ETF0.03%27/02/2026
VTVanguard Total World Stock ETF0.02%31/01/2026
VSGXVanguard ESG International Stock ETF0.01%31/01/2026
VEXCVanguard Emerging Markets Ex-China ETF0.001%31/01/2026
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.